微角膜刀辅助板层角膜移植术治疗圆锥角膜的十年结局
单中心干预性病例系列纳入151只连续圆锥角膜眼,评估改良微角膜刀辅助板层角膜移植术的10年结局。术后3年最佳矫正视力显著改善并维持至10年,免疫排斥和移植失败累积风险低,无复发性角膜扩张。
要点
- 术后3年BSCVA从基线0.89±0.31 logMAR显著改善至0.10±0.12 logMAR并维持至10年。
- 10年时94%眼BSCVA≥20/40,61%≥20/25,24%≥20/20。
- 10年免疫排斥和移植失败累积风险分别为8.5%和2.4%,无复发性角膜扩张。
核心结论
- 改良微角膜刀辅助板层角膜移植术在至少10年内获得稳定的视力和屈光结果,免疫排斥和移植失败率低,无复发性角膜扩张。
研究设计与样本
- 单中心干预性病例系列,纳入151只连续圆锥角膜眼,接受改良微角膜刀辅助板层角膜移植术。
- 排除瘢痕延伸至角膜基质后一半及术前最薄点厚度小于300微米的眼。
主要发现
- 基线BSCVA为0.89±0.31 logMAR,术后3年显著改善至0.10±0.12 logMAR(p<0.001),并稳定维持至10年。
- 10年时94%眼BSCVA≥20/40,61%≥20/25,24%≥20/20。
- 末次随访时屈光散光超过4.5D者5例(4%)。
- 术后1年内皮细胞丢失25±17%,10年内每年下降2%。
- 10年免疫排斥和移植失败累积风险分别为8.5%和2.4%,10年内无复发性角膜扩张。
临床怎么用
- 对于符合适应证的圆锥角膜眼,改良微角膜刀辅助板层角膜移植术可提供至少10年稳定的视力和屈光结果。
- 术后需关注内皮细胞密度变化及免疫排斥风险,但总体移植失败率低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: To report the 10-year outcomes of modified microkeratome-assisted lamellar keratoplasty (LK) for keratoconus. METHODS: In this single-centre interventional case series, 151 consecutive eyes with keratoconus underwent modified microkeratome-assisted LK. Eyes with scars extending beyond the posterior half of the corneal stroma and preoperative thinnest-point pachymetry value of less than 300 μm were excluded. Outcome measures were best spectacle-corrected visual acuity (BSCVA), refractive astigmatism (RA), endothelial cell density, immunological rejection, ectasia recurrence and graft failure rates. RESULTS: Baseline BSCVA (0.89±0.31 logarithm of the minimum angle of resolution (logMAR)) significantly improved to 0.10±0.12 logMAR at year 3 (p<0.001), and remained stable up to 10 years. At 10 years, 94% of eyes saw ≥20/40, 61% saw ≥20/25 and 24% saw ≥20/20 Snellen BSCVA. At final follow-up, RA exceeding 4.5 dioptres was observed in 5 cases (4%). Endothelial cell loss was 25±17% at 1 year with an annual decline of 2% over 10 years. The 10-year cumulative risk for immunological rejection and graft failure was 8.5%, and 2.4%, respectively. No case developed recurrent ectasia at 10 years. CONCLUSION: Modified microkeratome-assisted LK results in stable visual and refractive outcomes with low rates of immunological rejection and graft failure in the absence of recurrence of ectasia for at least 10 years.
引用
- Yu AC, Franco E, Caruso L, et al. Ten-year outcomes of microkeratome-assisted lamellar keratoplasty for keratoconus. Br J Ophthalmol. 2020. PMID: 33011685. doi:10.1136/bjophthalmol-2020-317253
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。